Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 281 K390 K325 K277 K306 K 1.3 M Research & development ————— — Operating income 19.99 M6.37 M21.36 M19.47 M21.5 M 68.7 M Non-Operating Income, Total 471 K494 K506 K528 K507 K 2.04 M Interest expense, net of interest capitalized 14.54 M13.95 M13.13 M13.13 M12.21 M 52.41 M Non-Operating Income, excl. Interest Expenses -14.07 M-13.45 M-12.62 M-12.6 M-11.71 M -50.38 M Unusual income/expense ————— — Pretax income 6.89 M596 K8.28 M7.92 M8.05 M 24.84 M Equity in earnings ————— — Taxes 1.51 M-92 K1.82 M1.84 M1.82 M 5.38 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 5.38 M688 K6.47 M6.08 M6.23 M 19.46 M Discontinued operations ————— — Net income 5.38 M688 K6.47 M6.08 M6.23 M 19.46 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 5.38 M688 K6.47 M6.08 M6.23 M 19.46 M Basic earnings per share (Basic EPS) 0.780.10.950.90.92 2.87 Diluted earnings per share (Diluted EPS) 0.770.10.950.890.91 2.85 Average basic shares outstanding 6.91 M6.87 M6.78 M6.83 M6.79 M — Diluted shares outstanding 6 9646 8966.79 M6 8596.81 M — EBITDA 4.35 M-8.41 M7.76 M6.05 M7.76 M 13.16 M EBIT 4.92 M-8.08 M8.32 M5.83 M8.45 M 14.52 M Cost of revenue 712 K7.41 M-225 K554 K298 K 8.03 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) -566 K-322 K-553 K213 K-692 K -1.35 M